Skip to main content
Hit enter to search or ESC to close
Close Search
RIS RxRIS Rx
Menu
  • Our Platform
  • Insights
  • Our Story
  • Get My GTN Assessment

    Leslie Donato

    Board Member
    Leslie Donato

    Leslie Donato

    Board Member

    Leslie Donato is a seasoned healthcare executive with over 30 years of experience in strategy, commercialization, and growth. She most recently served as EVP and Chief Strategy Officer at Cencora, where she led transformative M&A and helped drive significant market value growth. Previously, she held leadership roles at Bayer Healthcare Pharmaceuticals and spent 14 years as a Principal at McKinsey & Company. She currently serves on the boards of Keenova Therapeutics, COPILOT Provider Support Services, and Virtua Health. Leslie holds a BA in Economics and Public Policy from Swarthmore College and an MBA from the Wharton School of Business.

    Learn why the world's top pharmaceutical companies trust RIS Rx to protect their patients and improve GTN.

    "*" indicates required fields

    Consent*
    GTN areas I‘d like to explore:
    • Our Platform
    • Insights
    • Our Story
    • Contact
    • Careers
    • Press
    Get My GTN Assessment

    RIS Rx offers real-time GTN Revenue Protection to the world's leading pharmaceutical manufacturers, ensuring that every dollar allocated for affordability reaches the right patient at the right time.

    • Sitemap
    • Terms of Use
    • Privacy Policy
    • Cookie Settings
    • Do Not Sell My Personal Information
    Close Menu
    • Our Platform
    • Insights
    • Our Story
    • Get Assessment

    RIS Rx is pioneering real-time GTN Revenue Protection for the world's leading pharmaceutical manufacturers, ensuring that every dollar allocated for affordability reaches the right patients at the right time.